HCN3 IDG ionchannel ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with HCN3 IDG ionchannel ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with HCN3 IDG ionchannel ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with HCN3 IDG ionchannel ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with HCN3 IDG ionchannel ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

POU class 3 homeobox 3

Gene

ATPase H+ transporting V1 subunit G2

Gene

heterogeneous nuclear ribonucleoprotein A1 pseudogene 29

Gene

OFD1 pseudogene 7 Y-linked

Gene

DIRAS family GTPase 1

Gene

collapsin response mediator protein 1

Gene

zinc finger CCCH-type containing 13

Gene

tetratricopeptide repeat domain 9B

Gene

catenin delta 2

Gene

amyloid beta precursor protein binding family B member 1

  • Gene

    POU class 3 homeobox 3


  • Gene

    ATPase H+ transporting V1 subunit G2


  • Gene

    heterogeneous nuclear ribonucleoprotein A1 pseudogene 29


  • Gene

    OFD1 pseudogene 7 Y-linked


  • Gene

    DIRAS family GTPase 1


  • Gene

    collapsin response mediator protein 1


  • Gene

    zinc finger CCCH-type containing 13


  • Gene

    tetratricopeptide repeat domain 9B



  • Gene

    amyloid beta precursor protein binding family B member 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.